Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BALK AHMM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Holweg, CTJ; Baan, CC; Niesters, HGM; Vantrimpont, PJMJ; Mulder, PGH; Maat, APWM; Weimar, W; Balk, AHMM
      TGF-beta 1 gene polymorphisms in patients with end-stage heart failure

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    2. de Groot-Kruseman, HA; Baan, CC; Loonen, EHM; Mol, WM; Niesters, HGM; Maat, APWM; Balk, AHMM; Weimar, W
      Failure to down-regulate intragraft cytokine mRNA expression shortly afterclinical heart transplantation is associated with high incidence of acute rejection

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    3. Elhendy, A; van Domburg, RT; Vantrimpont, P; Sozzi, FB; Bax, JJ; Poldermans, D; Roelandt, JRTC; Maat, LPWM; Balk, AHMM
      Impact of heart transplantation on the safety and feasibility of the dobutamine stress test

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    4. de Leeuw, N; Ruiter, DJ; Balk, AHMM; de Jonge, N; Melchers, WJG; Galama, JMD
      Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy

      TRANSPLANT INTERNATIONAL
    5. Baan, CC; van Riemsdijk-van Overbeeke, IC; Balk, AHMM; Vantrimpont, PMAJ; Mol, WM; Knoop, CJ; Niesters, HGM; Maat, LPWM; Weimar, W
      Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression

      CLINICAL TRANSPLANTATION
    6. Hesse, CJ; Vantrimpont, P; van Riemsdijk-van Overbeeke, IC; van Gelder, T; Balk, AHMM; Weimar, W
      The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation

      TRANSPLANTATION PROCEEDINGS
    7. de Groot-Kruseman, HA; Baan, CC; Mol, WM; Niesters, HGM; Maat, APWM; Balk, AHMM; Weimar, W
      Cyclosporine A downregulates intragraft platelet-derived growth factor-alpha mRNA expression after clinical heart transplantation

      TRANSPLANTATION PROCEEDINGS
    8. Holweg, CTJ; Baan, CC; Balk, AHMM; Niesters, HGM; Maat, APWM; Mulder, PMG; Weimar, W
      The transforming growth factor-beta 1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation

      TRANSPLANTATION
    9. Baan, CC; Balk, AHMM; Holweg, CTJ; van Riemsdijk, IC; Maat, LPWM; Vantrimpont, PJMJ; Niesters, HGM; Weimar, W
      Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    10. Elhendy, A; Sozzi, FB; van Domburg, RT; Vantrimpont, P; Valkema, R; Krenning, EP; Roelandt, JRTC; Maat, LPWM; Balk, AHMM
      Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    11. Vaessen, LMB; van Miert, PPMC; van der Mast, BJ; Doumaid, K; Balk, AHMM; Boog, CJP; Weimar, W
      Immunologic monitoring of the beneficial effect of one HLA-DR-shared bloodtransfusion in heart transplant patients

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    12. Koelman, CA; Vaessen, LMB; Balk, AHMM; Weimar, W; Doxiadis, IIN; Claas, FHJ
      Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients

      TRANSPLANT IMMUNOLOGY
    13. Balk, AHMM
      Dilated cardiomyopathy, are a few drinks allowed?

      EUROPEAN HEART JOURNAL
    14. Baan, CC; van Gelder, T; Balk, AHMM; Knoop, CJ; Holweg, CTJ; Maat, LPWM; Weimar, W
      Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection

      TRANSPLANTATION
    15. van den Berg-Emons, HJG; Bussmann, JBJ; Balk, AHMM; Stam, HJ
      Validity of ambulatory accelerometry to quantify physical activity in heart failure

      SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE
    16. Wijbenga, AAM; Balk, AHMM; Jonkman, FAM; Boomsma, F; Simoons, ML; 't Veld, AJMI
      Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure

      EUROPEAN JOURNAL OF HEART FAILURE
    17. de Leeuw, N; Melchers, WJG; Balk, AHMM; de Jonge, N; Galama, JMD
      Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy

      CLINICAL INFECTIOUS DISEASES
    18. de Groot-Kruseman, HA; Baan, CC; Mol, WM; Niesters, HGM; Maat, APWM; Balk, AHMM; Weimar, W
      Intragraft platelet-derived growth factor-alpha and transforming growth factor-beta 1 during the development of accelerated graft vascular disease after clinical heart transplantation

      TRANSPLANT IMMUNOLOGY
    19. Balk, AHMM
      The 'heart failure nurse' to help us close the gap between what we can andwhat we do achieve

      EUROPEAN HEART JOURNAL
    20. Wijbenga, JAM; Balk, AHMM; Boomsma, F; in't Veld, AJM; Hall, C
      Cardiac peptides differ in their response to exercise - Implications for patients with heart failure in clinical practice

      EUROPEAN HEART JOURNAL
    21. van Riemsdijk-van Overbeeke, IC; Baan, CC; Niesters, HGM; Hesse, CJ; Loonen, EHM; Balk, AHMM; Maat, APWM; Weimar, W
      The TNF-alpha system in heart failure and after heart transplantation - Plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity

      EUROPEAN HEART JOURNAL
    22. de Groot-Kruseman, HA; Baan, CC; Mol, WM; Niesters, HGM; Maat, APWM; Balk, AHMM; Weimar, W
      Upregulated transforming growth factor-beta(1) mRNA expression in endomyocardial biopsies during the development of graft vascular disease after clinical heart transplantation

      TRANSPLANTATION PROCEEDINGS
    23. Baan, CC; Knoop, CJ; Holweg, CTJ; van Gelder, T; Metselaar, HJ; Niesters, HGM; Zondervan, PE; Balk, AHMM; Weimar, W
      The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantation

      TRANSPLANTATION PROCEEDINGS
    24. Baan, CC; Knoop, CJ; van Gelder, T; Holweg, CTJ; Niesters, HGM; Smeets, TJM; van der Ham, F; Zondervan, PE; Maat, LPWM; Balk, AHMM; Weimar, W
      Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation

      TRANSPLANTATION
    25. de Leeuw, N; Melchers, WJG; Ruiter, DJ; Caforio, ALP; Balk, AHMM; de Jonge, N; Galama, JMD
      Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy

      JOURNAL OF CLINICAL PATHOLOGY
    26. Vaessen, LMB; Daane, CR; Maat, APWM; Balk, AHMM; Claas, FHJ; Weimar, W
      T helper frequencies in peripheral blood reflect donor-directed reactivityin the graft after clinical heart transplantation

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    27. Wijbenga, AAM; Mosterd, A; Kasprzak, JD; Ligthart, JMR; Vletter, WB; Balk, AHMM; Roelandt, JRTC
      Potentials and limitations of the Valsalva maneuver as a method of differentiating between normal and pseudonormal left ventricular filling patterns

      AMERICAN JOURNAL OF CARDIOLOGY
    28. BAAN CC; HOLWEG CTJ; NIESTERS HGM; VANGELDER T; MOL WM; ZONDERVAN PE; MOCHTAR B; BALK AHMM; WEIMAR W
      THE NATURE OF ACUTE REJECTION IS ASSOCIATED WITH DEVELOPMENT OF GRAFTVASCULAR-DISEASE AFTER CLINICAL HEART-TRANSPLANTATION

      The Journal of heart and lung transplantation
    29. OSTERHAUS ADME; VOS MC; BALK AHMM; DEMAN RA; MOUTON JW; ROTHBARTH PH; SCHALM SW; TOMAELLO AM; NIESTERS HGM; VERBRUGH HA
      TRANSMISSION OF HEPATITIS-B VIRUS AMONG HEART-TRANSPLANT RECIPIENTS DURING ENDOMYOCARDIAL BIOPSY PROCEDURES

      The Journal of heart and lung transplantation
    30. VANEMMERIK NEM; VAESSEN LMB; KNOOP CJ; DAANE CR; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
      KINETICS OF CIRCULATING CYTOTOXIC T-LYMPHOCYTE PRECURSORS THAT HAVE AHIGH AVIDITY FOR DONOR ANTIGENS - CORRELATION WITH THE REJECTION STATUS OF THE HUMAN CARDIAC ALLOGRAFT

      Transplant immunology
    31. VANGELDER T; BALK AHMM; ZONDERVAN PE; MAAT AWPW; MOCHTAR B; VANDERMEER P; WEIMAR W
      C-REACTIVE PROTEIN IN THE MONITORING OF ACUTE REJECTION AFTER HEART-TRANSPLANTATION

      Transplant international
    32. VANGELDER T; BALK AHMM; ZIETSE R; HESSE C; MOCHTAR B; WEIMAR W
      RENAL-INSUFFICIENCY AFTER HEART-TRANSPLANTATION - A CASE-CONTROL STUDY

      Nephrology, dialysis, transplantation
    33. KOELMAN CA; MULDER A; JUTTE NHPM; VAESSEN LMB; BALK AHMM; WEIMAR W; DOXIADIS IIN; CLAAS FHJ
      THE APPLICATION OF HUMAN MONOCLONAL-ANTIBODIES FOR MONITORING DONOR DERIVED SOLUBLE HLA CLASS-I MOLECULES IN THE SERUM OF HEART-TRANSPLANT RECIPIENTS

      Human immunology
    34. WIJBENGA JAM; BALK AHMM; MEIJ SH; SIMOONS ML; MALIK M
      HEART-RATE-VARIABILITY INDEX IN CONGESTIVE-HEART-FAILURE - RELATION TO CLINICAL-VARIABLES AND PROGNOSIS

      European heart journal
    35. BAAN CC; KNOOP CJ; VANGELDER T; VANDERHAM F; ZONDERVAN PE; HOLWEG CTJ; MOCHTAR B; BALK AHMM; WEIMAR W
      CONTRIBUTION OF THE INFLAMMATORY RESPONSE TO CARDIAC ALLOGRAFT-REJECTION - HISTOPATHOLOGIC ANALYSIS OF SERIAL ENDOMYOCARDIAL BIOPSIES

      Transplantation proceedings
    36. VANGELDER T; BALK AHMM; ZIETSE R; HESSE C; MOCHTAR B; WEIMAR W
      SURVIVAL OF HEART-TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-INDUCED RENAL-INSUFFICIENCY

      Transplantation proceedings
    37. Weimar, W; van Besouw, NM; Baan, CC; Balk, AHMM
      Cytotoxic T lymphocytes and cytokines in graft vascular disease after clinical heart transplantation

      TRANSPLANTATION PROCEEDINGS
    38. VANEMMERIK NEM; KNOOP CJ; VAESSEN LMB; BALK AHMM; MOCHTAR B; CLASS FHJ; WEIMAR W
      C1.7 MONOCLONAL-ANTIBODY DESIGNATES HIGH-AVIDITY CD4(-LYMPHOCYTES INVOLVED IN CLINICAL HEART REJECTION() CYTOTOXIC T)

      Transplantation
    39. VANGELDER T; BAAN CC; BALK AHMM; KNOOP CJ; HOLWEG CTJ; VANDERMEER P; MOCHTAR B; ZONDERVAN PE; NIESTERS HGM; WEIMAR W
      BLOCKADE OF THE INTERLEUKIN (IL)-2 IL-2 RECEPTOR PATHWAY WITH A MONOCLONAL, ANTI-IL-2 RECEPTOR ANTIBODY (BT563) DOES NOT PREVENT THE DEVELOPMENT OF ACUTE HEART ALLOGRAFT-REJECTION IN HUMANS/

      Transplantation
    40. WIJBURG ER; BALK AHMM; VANHERWERDEN LA
      DOUBLE VALVE REPAIR IN A TRANSPLANTED HEART

      Journal of thoracic and cardiovascular surgery
    41. DELEEUW N; MELCHERS WJG; BALK AHMM; DEJONGE N; GALAMA JMD
      NO EVIDENCE FOR PERSISTENT ENTEROVIRUS INFECTION IN PATIENTS WITH END-STAGE IDIOPATHIC DILATED CARDIOMYOPATHY

      The Journal of infectious diseases
    42. VANBESOUW NM; LOONEN EHM; VAESSEN LMB; BALK AHMM; CLAAS FHJ; WEIMAR W
      THE FREQUENCY AND AVIDITY OF COMMITTED CYTOTOXIC T-LYMPHOCYTES (CCTL)FOR DONOR HLA CLASS-I AND CLASS-II ANTIGENS AND THEIR RELATION WITH GRAFT VASCULAR-DISEASE

      Clinical and experimental immunology
    43. JUTTE NHPM; KNOOP CJ; HEIJSE P; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
      CYTOTOXICITY OF GRAFT-DERIVED LYMPHOCYTES - SPECIFIC FOR DONOR HEART ENDOTHELIAL-CELLS

      The Journal of heart and lung transplantation
    44. VANEMMERIK NEM; LOONEN EHM; VAESSEN LMB; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
      THE AVIDITY, NOT THE MERE PRESENCE, OF PRIMED CYTOTOXIC T-LYMPHOCYTESFOR DONOR HUMAN-LEUKOCYTE CLASS-II ANTIGENS DETERMINES THEIR CLINICALRELEVANCE AFTER HEART-TRANSPLANTATION

      The Journal of heart and lung transplantation
    45. BAAN CC; VANBESOUW NM; DAANE CR; BALK AHMM; MOCHTAR B; NIESTERS HGM; WEIMAR W
      KINETICS OF IL-2 AND IL-4 MESSENGER-RNA AND PROTEIN-PRODUCTION BY GRAFT-INFILTRATING LYMPHOCYTES RESPONSIBLE FOR REJECTION AFTER CLINICAL HEART-TRANSPLANTATION

      Transplant immunology
    46. BAAN CC; HOLWEG CTJ; NIESTERS HGM; VANGELDER T; MOL WM; MOCHTAR B; BALK AHMM; WEIMAR W
      INTRAGRAFT CYTOKINE AND GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN RELATION TO GRAFT VASCULAR-DISEASE AFTER HEART-TRANSPLANTATION

      Transplantation proceedings
    47. VANBESOUW NM; DAANE CR; VAESSEN LMB; VANGELDER T; MOCHTAR B; BALK AHMM; WEIMAR W
      NONSPECIFIC IMMUNE REACTIVITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IS RELATED TO GRAFT VASCULAR-DISEASE

      Transplantation proceedings
    48. VANBESOUW NM; DAANE CR; VAESSEN LMB; MOCHTAR B; BALK AHMM; WEIMAR W
      DONOR-SPECIFIC CYTOKINE PRODUCTION BY GRAFT-INFILTRATING LYMPHOCYTES INDUCES AND MAINTAINS GRAFT VASCULAR-DISEASE IN HUMAN CARDIAC ALLOGRAFTS

      Transplantation
    49. VANDERMAST BJ; BALK AHMM
      EFFECT OF HLA-DR-SHARED BLOOD-TRANSFUSION ON THE CLINICAL OUTCOME OF HEART-TRANSPLANTATION

      Transplantation
    50. VANEMMERIK NEM; DAANE CR; KNOOP CJ; HESSE C; VAESSEN LMB; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
      THE AVIDITY OF ALLOSPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) DETERMINES THEIR CYTOKINE PRODUCTION PROFILE

      Clinical and experimental immunology
    51. VANSUYLEN RJ; VANBEKKUM EEC; BOERSMA H; DEKOK LB; BALK AHMM; BOS E; BOSMAN FT
      COLLAGEN CONTENT AND DISTRIBUTION IN THE NORMAL AND TRANSPLANTED HUMAN HEART - A POSTMORTEM QUANTITATIVE LIGHT-MICROSCOPIC ANALYSIS

      Cardiovascular pathology
    52. BAAN CC; NIESTERS HGM; BALK AHMM; MOCHTAR B; ZONDERVAN PE; WEIMAR W
      THE INTRAGRAFT CYTOKINE MESSENGER-RNA PATTERN REFLECTS THE EFFICACY OF STEROID ANTIREJECTION THERAPY

      The Journal of heart and lung transplantation
    53. DEVITOHAYNES LD; JANKOWSKAGAN E; HEISEY D; JUTTE NHPM; BALK AHMM; WEIMAR W; CLAAS FHJ; WARNER TFC; MENTZER RM; LOVE RB; BURLINGHAM WJ
      DONOR-DERIVED HUMAN-LEUKOCYTE ANTIGEN CLASS-I PROTEINS IN THE SERUM OF HEART-TRANSPLANT RECIPIENTS

      The Journal of heart and lung transplantation
    54. VANTOORENENBERGEN AW; BALK AHMM; VERMEULEN AM
      SUSTAINED DECREASE OF SERUM TOTAL IGE IN CARDIAC TRANSPLANT RECIPIENTS

      International archives of allergy and immunology
    55. VANBESOUW NM; VAESSEN LMB; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
      CSA THERAPY AFFECTS THE DIRECT AND INDIRECT ANTIGEN-PRESENTATION PATHWAY IN CARDIAC ALLOGRAFT RECIPIENTS

      Transplantation proceedings
    56. BAAN CC; NIESTERS HGM; BALK AHMM; MOCHTAR B; ZONDERVAN PE; VANGELDER T; WEIMAR W
      STEROID RESISTANCE IN CLINICAL HEART-TRANSPLANTATION - THE ROLE OF SIMULTANEOUS IL-2 AND IL-4 MESSENGER-RNA EXPRESSION

      Transplantation proceedings
    57. VANEMMERIK NEM; VAESSEN LMB; BALK AHMM; BOS E; CLAAS FHJ; WEIMAR W
      PROGRESSIVE ACCUMULATION OF CTL WITH HIGH AVIDITY FOR DONOR ANTIGENS DURING THE DEVELOPMENT OF ACUTE CARDIAC REJECTION

      Transplantation
    58. JUTTE NHPM; KNOPP CJ; HEIJSE P; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
      HUMAN HEART ENDOTHELIAL-CELL-RESTRICTED ALLORECOGNITION

      Transplantation
    59. VANGELDER T; BALK AHMM; JONKMAN FAM; ZIETSE R; ZONDERVAN P; HESSE CJ; VAESSEN LMB; MOCHTAR B; WEIMAR W
      A RANDOMIZED TRIAL COMPARING SAFETY AND EFFICACY OF OKT3 AND A MONOCLONAL ANTI-INTERLEUKIN-8 RECEPTOR ANTIBODY (BT563) IN THE PREVENTION OFACUTE REJECTION AFTER HEART-TRANSPLANTATION

      Transplantation
    60. VANBESOUW NM; VAESSEN LMB; DAANE CR; JUTTE NHPM; BALK AHMM; CLASS FHJ; WEIMAR W
      PERIPHERAL MONITORING OF DIRECT AND INDIRECT ALLOANTIGEN PRESENTATIONPATHWAYS IN CLINICAL HEART-TRANSPLANT RECIPIENTS

      Transplantation
    61. VANBESOUW NM; DAANE CR; VAESSEN LMB; BALK AHMM; CLAAS FHJ; ZONDERVAN PE; JUTTE NHPM; WEIMAR W
      DIFFERENT PATTERNS IN DONOR-SPECIFIC PRODUCTION OF T-HELPER-1 AND T-HELPER-2 CYTOKINES BY CELLS INFILTRATING THE REJECTING CARDIAC ALLOGRAFT

      The Journal of heart and lung transplantation
    62. VANGELDER T; MULDER AH; BALK AHMM; MOCHTAR B; HESSE CJ; BAAN CC; VAESSEN LMB; WEIMAR W
      INTEGRAFT MONITORING OF REJECTION AFTER PROPHYLACTIC TREATMENT WITH MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) IN HEART-TRANSPLANT RECIPIENTS

      The Journal of heart and lung transplantation
    63. ZIETSE R; BLANKESTIJN PJ; POS B; BALK AHMM; DERKX FHM; WEIMAR W; SCHALEKAMP MADH
      OPTIMIZING GLOMERULAR-FILTRATION RATE AND EFFECTIVE RENAL PLASMA-FLOWMEASUREMENTS USING A SIMPLE PHARMACOKINETIC MODEL

      Clinical nephrology
    64. HESSE CJ; VANGELDER T; VAESSEN LMB; KNOOP CJ; BALK AHMM; YZERMANS JNM; JUTTE NHPM; WEIMAR W
      PHARMACODYNAMICS OF PROPHYLACTIC ANTIREJECTION THERAPY WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY (BT563) AFTER HEART AND KIDNEY-TRANSPLANTATION

      Immunopharmacology
    65. BAAN CC; VAESSEN LMB; LOONEN EHM; BALK AHMM; JUTTE NHPM; CLAAS FHJ; WEIMAR W
      THE EFFECT OF ANTITHYMOCYTE GLOBULIN THERAPY ON FREQUENCY AND AVIDITYOF ALLOSPECIFIC COMMITTED CTL IN CLINICAL HEART-TRANSPLANTS

      Transplantation proceedings
    66. VAESSEN LMB; BAAN CC; DAANE CR; LOONEN EHM; BALK AHMM; JUTTE NHPM; MOCHTAR B; CLAAS FHJ; WEIMAR W
      IMMUNOLOGICAL MONITORING IN PERIPHERAL-BLOOD AFTER HEART-TRANSPLANTATION - FREQUENCIES OF T-HELPER CELLS AND PRECURSORS OF CYTOTOXIC T-CELLS WITH HIGH AVIDITY FOR DONOR ANTIGENS CORRELATE WITH REJECTION

      Transplantation proceedings
    67. VANGELDER T; KNOOP CJ; HESSE CJ; VAESSEN LMB; BALK AHMM; YZERMANS JNM; WEIMAR W
      PERIPHERAL-BLOOD MONITORING DURING AND AFTER REJECTION-PROPHYLAXIS WITH A MONOCLONAL ANTI-INTERLEUKIN-2-RECEPTOR ANTIBODY IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS

      Transplantation proceedings
    68. ARNESE M; CORNEL JH; SALUSTRI A; MAAT APWM; ELHENDY A; REIJS AEM; TENCATE FJ; KEANE D; BALK AHMM; ROELANDT JRTC; FIORETTI PM
      PREDICTION OF IMPROVEMENT OF REGIONAL LEFT-VENTRICULAR FUNCTION AFTERSURGICAL REVASCULARIZATION - A COMPARISON OF LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY WITH TL-201 SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY

      Circulation
    69. OUWEHAND AJ; BAAN CC; VAESSEN LMB; JUTTE NHPM; BALK AHMM; BOS E; CLAAS FHJ; WEIMAR W
      CHARACTERISTICS OF GRAFT-INFILTRATING LYMPHOCYTES AFTER HUMAN HEART-TRANSPLANTATION - HLA MISMATCHES AND THE CELLULAR IMMUNE-RESPONSE WITHIN THE TRANSPLANTED HEART

      Human immunology
    70. KROES ACM; DEMAN RA; NIESTERS HGM; SCHALM SW; WEIMAR W; BALK AHMM
      FATAL HEPATITIS-C VIRUS-INFECTION IN A HEART-TRANSPLANT RECIPIENT DETECTABLE BY POLYMERASE CHAIN-REACTION ONLY

      Journal of hepatology
    71. OUWEHAND AJ; BALK AHMM; BAAN CC; VAESSEN LMB; JUTTE NHPM; BOS E; CLAAS FHJ; WEIMAR W
      CYTOMEGALOVIRUS-INFECTION AND ALLOSPECIFIC CYTOTOXIC ACTIVITY OF GRAFT-INFILTRATING CELLS AFTER HEART-TRANSPLANTATION

      Journal of medical virology
    72. BAAN CC; VAESSEN LMB; BALK AHMM; MOCHTAR B; JUTTE NHPM; CLAAS FHJ; WEIMAR W
      CYCLOSPORINE-A SENSITIVITY OF ALLO-SPECIFIC PRECURSOR AND COMMITTED CYTOTOXIC T-LYMPHOCYTES AFTER CLINICAL HEART-TRANSPLANTATION

      Transplantation proceedings
    73. VAESSEN LMB; BAAN CC; OUWEHAND AJ; BALK AHMM; JUTTE NHPM; MOCHTAR B; CLAAS FHJ; WEIMAR W
      DIFFERENTIAL AVIDITY AND CYCLOSPORINE SENSITIVITY OF COMMITTED DONOR-SPECIFIC GRAFT-INFILTRATING CYTOTOXIC T-CELLS AND THEIR PRECURSORS - RELEVANCE FOR CLINICAL CARDIAC GRAFT-REJECTION

      Transplantation
    74. JUTTE NHPM; GROENEVELD K; BALK AHMM; OUWEHAND AJ; LOONEN EHM; VANDERLINDEN M; STRIKWERDA S; MOCHTAR B; CLAAS FHJ; WEIMAR W
      THE DEVELOPMENT OF TRANSPLANT CORONARY-ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION IS CORRELATED WITH A PREDOMINANCE OF CD8(-LYMPHOCYTES IN ENDOMYOCARDIAL BIOPSY DERIVED T-CELL CULTURES() T)

      Clinical and experimental immunology
    75. BAAN CC; VANEMMERIK NEM; BALK AHMM; QUINT WGV; MOCHTAR B; JUTTE NHPM; NIESTERS HGM; WEIMAR W
      CYTOKINE MESSENGER-RNA EXPRESSION IN ENDOMYOCARDIAL BIOPSIES DURING ACUTE REJECTION FROM HUMAN HEART-TRANSPLANTS

      Clinical and experimental immunology
    76. IDEMA RN; VANDENMEIRACKER AH; BALK AHMM; BOS E; SCHALEKAMP MADH; TVELD AJMI
      ABNORMAL DIURNAL-VARIATION OF BLOOD-PRESSURE, CARDIAC-OUTPUT, AND VASCULAR-RESISTANCE IN CARDIAC TRANSPLANT RECIPIENTS

      Circulation
    77. IDEMA RN; VANDENMEIRACKER AH; BALK AHMM; BOS E; SCHALEKAMP MADH; MANINTVELD AJ
      DECREASED CIRCADIAN BLOOD-PRESSURE VARIATION UP TO 3 YEARS AFTER HEART-TRANSPLANTATION

      The American journal of cardiology
    78. BALK AHMM; WEIMAR W; ROTHBARTH PH; MEETER K; METSELAAR HJ; MOCHTAR B; SIMOONS ML
      PASSIVE-IMMUNIZATION AGAINST CYTOMEGALOVIRUS IN ALLOGRAFT RECIPIENTS - THE ROTTERDAM HEART-TRANSPLANT PROGRAM EXPERIENCE

      Infection
    79. IDEMA RN; VANDENMEIRACKER AH; MANINTVELD AJ; BALK AHMM; BOS E; SCHALEKAMP MADH
      CIRCADIAN HEMODYNAMICS IN HEART-TRANSPLANT RECIPIENTS

      Journal of hypertension
    80. VANDENMEIRACKER AH; TULEN JHM; MANINTVELD AJ; BALK AHMM; VANSTEENIS HG; SCHALEKAMP MADH
      BLOOD-PRESSURE AND HEART-RATE-VARIABILITY IN CLINICAL-MODELS OF CARDIAC DENERVATION, SYMPATHICOLYSIS AND SYMPATHICO- AND PARASYMPATHICOLYSIS

      Journal of hypertension
    81. OUWEHAND AJ; BAAN CC; ROELEN DL; VAESSEN LMB; BALK AHMM; JUTTE NHPM; BOS E; CLAAS FHJ; WEIMAR W
      THE DETECTION OF CYTOTOXIC T-CELLS WITH HIGH-AFFINITY RECEPTORS FOR DONOR ANTIGENS IN THE TRANSPLANTED HEART AS A PROGNOSTIC FACTOR FOR GRAFT-REJECTION

      Transplantation
    82. GROEN HJM; BOGAARD JM; BALK AHMM; KHO SG; HOP WCJ; HILVERING C
      DIFFUSION CAPACITY IN HEART-TRANSPLANT RECIPIENTS

      Chest
    83. DIMARIO C; KRAMS R; BALK AHMM; VERDOUW PD; ROELANDT JRTC
      CAN THE ZERO-FLOW PRESSURE BE EXTRAPOLATED FROM THE FLOW VELOCITY-PRESSURE RELATION DURING LONG DIASTOLIC PAUSES IN HUMANS

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 19:19:35